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Abstract:  Nod-like receptors have emerged as an important family of sensors in host 
defense. These receptors are expressed in macrophages, dendritic cells and monocytes and 
play an important role in microbial immunity. Some Nod-like receptors form the 
inflammasome, a protein complex that activates caspase-1 in response to several stimuli. 
Caspase-1 activation leads to processing and secretion of pro-inflammatory cytokines such 
as interleukin (IL)-1β and IL-18. Here, we discuss recent advances in the inflammasome 
field with an emphasis on host defense. We also compare differential requirements for 
inflammasome activation in dendritic cells, macrophages and monocytes. 
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(Podospora anserine incompatibility locus protein) and telomerase associated protein; NAD—
NACHT-associated domain; NAIP–neuronal apoptosis inhibitor protein; PYD—pyrin domain; GBP—
GTP binding domain; NF-κB—nuclear factor kappa-light-chain-enhancer of activated B cells; ESX-1 
(ESAT-6 secretion system-1); ROS—Reactive oxygen species; LPS—lipopolysaccharide. 





A quick immune response defines life and death for the host. To detect infection quickly, the 
immune system relies on innate immunity, the first line of defense against microbial infection that 
engages adaptive immunity [1]. Several families of innate immune receptors have been described 
[2,3]. These receptor families include Toll-like receptors (TLRs), retinoic acid-inducible gene I-like 
receptors (RLRs), and nucleotide-binding oligomerization domain-like receptors (NLRs). TLRs are 
membrane bound receptors located either in the plasma membrane or on vesicles of the endocytic 
pathway [4]. TLRs are widely studied and detect microbial pathogens that include viruses, bacteria, 
protozoa, and fungi. TLR recognition of pathogen-associated molecular patterns is done via 
extracellular leucine-rich repeat motifs that transmit signals through the cytoplasmic Toll-interleukin 
(IL)-1 receptor (TIR) domain [5]. RLRs are distinct from the TLR pathway and recognize viral RNA 
present within the cytoplasm [3]. RLRs proteins have a RNA-binding helicase domain and two amino 
(N)-terminal caspase recruitment domains (CARDs) for propagation to the interferon-regulatory factor 
and NF-κB signaling pathways [6,7]. 
Figure 1. NLR domain structures. The domain structures of seven NLR members are 
shown. The CARD domain depicted in CIITA is only present in some splice forms. 
Abbreviations: BIR, baculovirus IAP (inhibitor of apoptosis protein) repeat; CARD, 
caspase-recruitment domain; CIITA, major histocompatibility complex (MHC) class II 
transactivator; FIIND, domain with a function to find; NLRC4/IPAF, interleukin   
1β-converting enzyme protease-activating factor; LRR, leucine-rich repeat; NACHT, 
domain present in NAIP, CIITA, HET-E (incompatibility locus protein from Podospora 
anserine) and telomerase associated protein; NAD, NACHT-associated domain; NAIP, 
neuronal apoptosis inhibitor protein; PYD, pyrin domain; GBP, GTP binding domain. 




NLRs are a family of intracellular sensors that have key roles in innate immunity and   
inflammation [8-11]. NLRs are defined by an architecture that contains a N-terminus, a middle 
nucleotide binding and oligomerization domain, and a leucine-rich repeat domain that is variable in the 
repeats composition and number (Figure 1). A number of NLR family members can form multiprotein 
complexes, called inflammasomes, and are capable of activating the cysteine protease caspase-1 in 
response to a wide range of stimuli including both microbial and self-molecules. NLRs induce the 
recruitment of the adaptor molecule ASC (apoptosis associated speck-like protein containing a 
CARD), leading to the processing and activation of pro-IL-1β and IL-18 through caspase-1. NLRs are 
mostly cytosolic and structurally related to the disease resistant protein family (R protein) [12]. In this 
review we will discuss the mechanisms by which the inflammasome is activated in cells. A greater 
emphasis will be placed on a broader function of the inflammasome in host defense. We will elaborate 
on the cross-talk between the inflammasome and other signaling pathways. We also review 
mechanisms of inflammasome activation according to the environment in which each cell type is 
located. We make a distinction between findings observed in macrophages, dendritic cells and 
monocytes. We apologize in advance to those whose work could not be cited due to space constraints.   
2. The Inflammasome 
In humans the NLR family is composed of 22 members [10]. They are divided into subfamilies 
according to their N-terminal effector domains. The effector domains lead to inflammatory caspase or 
NF-κB activation. In humans, 14 NLR members share a pyrin effector domain. Five other members are 
part of the NOD subfamily. CIITA, NLRC4/IPAF and the BIR-containing NAIP form the remaining 
NLR members.  Earlier nomenclature was confusing; however, a standardized nomenclature has 
recently been proposed, and we will use it throughout this review [13]. NLR molecules have been 
shown to form a complex with caspase-1 and the adaptor molecule ASC termed the inflammasome. 
The term inflammasome was coined to describe a complex of proteins that activates caspase-1 and the 
cytokine IL-1β. Inflammasome is derived from the word inflammation and the suffix “some”, which is 
used to define molecular complexes [10]. This term was also chosen to highlight functional similarities 
with another platform that triggers apoptosis—the apoptosome [14]. The central effector molecule of 
the inflammasome is the cysteine protease caspase-1 that, upon activation cleaves cytosolic pro-IL-1β, 
pro-IL-18 to their active forms. Recent studies have shown that the NLRP1, NLRP3, and NLRC4 
inflammasomes have a clear role in host defense (Figure 2). These distinct inflammasomes are 
described below.  




Figure 2. Mechanisms of inflammasome activation. Three different NLRs regulate the 
inflammasome. The NLRC4 inflammasome is triggered by microbial components secreted 
by bacterial secretion systems. The NLRP1/NALP1 inflammasome is associated with 
susceptibility to the Bacillus anthracis lethal toxin. Microbial toxins and danger signals 
trigger the NLRP3/NALP3 inflammasome. Crystals cause lysosome damage and protein 
leakage to the cytosol. Response to the NLRP3/NALP3 inflammasome triggers reactive 
oxygen species and potassium efflux although it is not clear how the signaling   
cascade operates. 
 
2.1. The NLRP1/NALP1 Inflammasome 
The NLRP1/NALP1 inflammasome (also known as DEFCAP, NAC, CARD7 and CLR17.1) is 
formed as a reconstituted complex enriched for caspase-1, caspase-5, and the adaptor molecule   
ASC [15]. Reed and colleagues have demonstrated that the minimal components for inflammasome 
activation are NLRP1/NALP1 and caspase-1 in the presence of ribonucleotides [16]. The bacterial cell 
wall component muramyl dipeptide (MDP) strongly activates the inflammasome in-vitro, although 
direct binding of MDP to NLRP1/NALP1 was not demonstrated.  
The adaptor molecule ASC was not required for NLRP1/NALP1 inflammasome activation although 
its presence did enhance caspase-1 activation. NLRP1/NALP1 also plays a role in anthrax   
immunity [17-23]. Bacillus anthracis lethal toxin (LT) can induce caspase-1-dependent cell death of 
macrophages. Boyden and Dietrich revealed that the NLRP1/NALP1b gene, one of three paralogues of 
NLRP1/NALP1 in mice, is responsible for macrophage susceptibility to LT [18]. Hsu et al. have also 
shown that NLRP1/NALP1 plays a role in LT-induced caspase-1-dependent IL-1β secretion in 
response to intact B. anthracis [24]. This study demonstrated that NOD2 was required for B. anthracis-
induced IL-1β secretion, suggesting that NOD2 may interact with the NLRP1/NALP1 inflammasome. 
Interestingly, the group of Tschopp has demonstrated that mouse effector and memory CD4




abolish macrophage inflammasome-mediated caspase-1 activation and interleukin-1β. Inhibition of the 
inflammasome is observed for NLRP1/NALP1, NLRP3/NALP3 and the NLRC4/IPAF protein 
complexes [25]. 
2.2. The NLRC4/Ipaf Inflammasome 
The NLRC4/Ipaf inflammasome (also known as CARD12, CLR2.1 and CLAN) is important for 
caspase-1 activation in response to Salmonella, Pseudomonas, Legionella, Listeria, Anaplasma and 
Shigella [26-38]. NLRC4/IPAF responds to the presence of flagellin within the
 macrophage cytosol 
during infection by Salmonella  [27,30,39],  Legionella [26,40-47] and Pseudomonas [29,33,34]. 
Shigella, however, does not express flagellin, suggesting that NLRC4/IPAF may signal through a 
molecule independently
  of flagellin expression [36,37]. For Legionella infection, Vance and   
colleagues [47] have generated mice deficient in the intracellular sensor Naip5/Birc1e/NLRB1 and 
have elegantly demonstrated that these mice fail to activate the inflammasome in response to a 
segment of the carboxyl terminus of flagellin. Signaling mechanisms that form the NLRC4/IPAF 
inflammasome has been recently expanded. Using Legionella as a model pathogen, Akhter et al. [48] have 
demonstrated that caspase-7 was activated downstream of the NLRC4/ IPAF inflammasome and 
required caspase-1 activation. Caspase-7 activation was mediated by flagellin and required a functional 
Naip5 [49,50]. 
2.3. The NLRP3/NALP3 Inflammasome 
The NLRP3/NALP3 (also known as cryopyrin, CIAS1, PYPAF1 and CLR1.1) is the best-studied 
inflammasome and is activated by chemically and structurally diverse stimuli—i.e., malarial 
hemozoin, crystal structures and fungal toxins, viral RNA, among others [8,51-68]. LPS and 
extracellular ATP stimulate caspase-1 in a NLRP3/NALP3 dependent fashion [54,55]. ATP activates 
the purinergic receptor P2X7, which recruits another hemichannel—pannexin-1. Pannexin-1 forms a 
larger pore of the P2X7 purinergic receptor upon activation and is important for caspase-1   
activation [69-72]. Pannexin-1 channels can be activated by high extracellular K
+. Activation of 
pannexin-1 channels by extracellular K
+ occurs in cells voltage-clamped to the resting membrane 
potential. Therefore, it cannot occur due to the depolarization resulting from the elimination of the 
transmembrane K
+ gradient.  It is unclear whether K
+ activation of pannexin 1 channels occurs   
in vivo. Despite a well-documented role of K
+ ions in the NLRP3/NALP3 inflammasome in-vitro, the 
mechanism of action is poorly understood.  
The NLRP3/NALP3 inflammasome assembly occurs when potassium efflux inducing agents such 
as nigericin, Listeria LLO, Aeromonas  aerolysin, and maiotoxin induce the formation of plasma 
membrane pores [53,55]. Mycobacterium tuberculosis, through its ESX-1 secretion system, has been 
shown to activate the NLRP3/NALP3 inflammasome [73]. DNA, bacterial RNA and the antiviral 
imidazoquinoline compounds R837 and R848 also induce the NLRP3/NALP3 inflammasome [57,59]. 
However, four independent groups have recently demonstrated that immune detection of foreign 
dsDNA in the cytoplasm occurs primarily through the AIM2—a member of the HIN-200 family of  
IFN-inducible proteins that recruits ASC and caspase-1 [74-77]. Particulate matter such as gout and 




fungal infection activate the NLRP3/NALP3 inflammasome in a P2X7-independent manner [49,56,78-82]. 
Silica and aluminum salt crystals activate the NLRP3/NALP3 inflammasome through phagocytosis [60]. 
Crystals induced lysosome swelling, damage and leakage of proteins to the cytosol. The inhibition of a 
lysosomal protein -cathepsin B- leads to a significant decrease in NLRP3/NALP3 activation [58,83,84]. 
Two events that appear to be required for both toxin- and crystal-mediated NLRP3/NALP3 
inflammasome activation are efflux of intracellular potassium and the generation of reactive oxygen 
species (ROS). A decrease in intracellular potassium concentrations may be required for assembly of 
the NLRP3/NALP3 inflammasome, however, the precise role of potassium in this process is   
unknown [85]. Similarly blockade of ROS production using chemical inhibitors has been shown to 
mitigate the ability of silica, asbestos and ATP to activate the NLRP3/NALP3 inflammasome [85-88]. 
Ng and colleagues demonstrated that uric acid crystals could directly engage cholesterol rich cellular 
membranes resulting in the activation of a Syk kinase-dependent signaling cascade [89]. Syk kinase 
signaling was also coupled to the NLRP3/NALP3 inflammasome for anti-fungal host defense.  
3. Inflammasome Activation Requirements  
Dendritic cells, macrophages and circulating monocytes must respond to microbial threats and are 
essential to host defense. Inflammasome activation in monocytes and dendritic cells and macrophages 
are different.  Two fundamental differences exist for inflammasome activation in dendritic cells, 
macrophages and circulating monocytes. While monocytes have constitutively activated caspase-1, the 
activation of caspase-1 in dendritic cells and macrophages needs to be induced.  
Figure 3. Differential requirements for inflammasome activation in immune cells. 
Caspase-1 is constitutively activated in circulating monocytes and release mature IL-1β 
after a single stimulation with TLR ligands such as LPS. IL-1β secretion is induced by 
endogenously released ATP. Dendritic cells and macrophages, however, need double 
stimulation: the first stimulus may be a TLR ligand (e.g., LPS), which induces transcription 
of IL-1β via NF-κB. The second stimulus (e.g., exogenous ATP, bacterial toxins) triggers 
NLR and caspase-1 activation followed by IL-1β secretion. 




Furthermore, monocytes are capable of releasing endogenous ATP [90]—an important molecule for 
inflammasome activation, whereas the lack of endogenous ATP by macrophages and dendritic cells 
renders these cells incapable of IL-1β secretion with one single stimulus. Netea and colleagues [91] 
have recently clarified these mechanisms. Monocytes only need a single TLR stimulus for IL-1β 
secretion, whereas dendritic cells and macrophages need a double stimulation—TLR (e.g., LPS) and 
NLR (e.g., ATP) stimuli (Figure 3). The reason for this differential regulation is poorly understood. 
Current evidence suggests an adaptation of each cell type to their respective environment. Circulating 
monocytes function in a pathogen-free environment and must promptly respond to a microbial threat. 
Dendritic cells and macrophages are confined to a non-sterile environment and are constantly exposed  
to microbial pathogens.  Therefore, a second checkpoint mechanism is necessary to avoid   
deleterious inflammation.  
The difference in inflammasome activation requirements does not seem to be restricted to 
macrophages, dendritic cells and monocytes. In contrast to monocytes and macrophages, in which low 
intracellular K
+ triggers inflammasome activation, neurons and astrocytes activate caspase-1 by high 
intracellular K
+ [92]. In epithelial cells, which do not secrete high levels of IL-1β, caspase-1 enhances 
lipid metabolism and is required for optimal growth of the intracellular bacterium Chlamydiae [68]. 
Mast cells were identified as the main cell population responsible for IL-1β in the skin of   
cryopyrin-associated periodic syndrome patients. Unlike normal mast cells that required stimulation 
with pro-inflammatory stimuli for IL-1β production, resident mast cells from cryopyrin-associated 
periodic syndrome patients constitutively produced IL-1β  via the NLRP3 inflammasome [93]. 
Collectively, these findings demonstrate that each cell type commits the inflammasome to the 
immediate environment in which they are located. This differential requirement for inflammasome 
activation operates to prevent accidental or uncontrolled inflammation, which may have devastated 
consequences for the host. A better understanding of the inflammasome activation in cells other than 
macrophages and dendritic cells may have significant ramifications for the treatment of infectious 
diseases and inflammatory disorders. 
4. Conclusions 
The cytoplasm was thought for a long time to be a safe haven for pathogenic microbes. Once 
viruses and intracellular bacteria evaded cell surface innate immune receptors, they could establish 
themselves into the cell interior, and replicate in it unabated.  Recent findings, however, have 
challenged this line of thinking. Newly discovered cytoplasmic defenses such as NLRs have been 
show to preserve the cytosolic environment against pathogenic microbes. The field of NLRs and the 
inflammasome has blossomed into an important area of innate immunity and inflammation. We have 
attempted to describe these latest findings with an emphasis on host defense. Several fundamental 
questions remain unanswered in the NLR and the inflammasome field. The first and foremost 
fundamental issue is related to whether NLR recognition of pathogen-associated molecular patterns is 
direct or indirect.  A second issue relates to the scope of the studies in field of the inflammasome. Most 
studies have been focused on macrophages and dendritic cells and three types of inflammasome—
NLRP1/NALP1, NLRP3/NALP3, and NLRC4/IPAF inflammasome. We reason that it is important to 




safer design of therapeutics.  A third issue that needs to be explored is the connection of the 
inflammasome with adaptive immunity. Although a few papers have emerged recently [25,94], it is 
poorly established how the inflammasome engages adaptive immunity in host defense. There are many 
roles for the inflammasome yet to be examined. The importance of the inflammasome in host defense 
makes this protein complex an attractive target for therapeutic intervention in microbial immunity. 
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